Showing results (521-530 of 1,019) with videos related to
Sort By:
Pageof 102
Journal of Pharmaceutical Policy and Practice|September 29, 2015
Accrediting retail drug shops to strengthen Tanzania's public health system: an ADDO case studyEdmund Rutta, Jafary Liana, Martha Embrey, et al.Journal of Pharmaceutical Policy and Practice|September 2, 2015
Access to and quality use of non-communicable diseases medicines in NepalBhuvan K C, Susan Heydon, Pauline NorrisJournal of Pharmaceutical Policy and Practice|April 9, 2016
Access to new cancer medicines in Australia: dispelling the myths and informing a public debateAgnes Vitry, Barbara Mintzes, Wendy LipworthJournal of Pharmaceutical Policy and Practice|April 23, 2016
A cross-sectional survey of pharmacists to understand their personal preference of brand and generic over-the-counter medications used to treat common health conditionsMira Patel, Marion Slack, Janet Cooley, et al.Journal of Pharmaceutical Policy and Practice|March 17, 2016
Navigating through the maze of pricing and affordability of branded pharmaceuticals in the midst of the financial crisis: a comparative study among five European recession countries, from a Cyprus perspectivePanagiotis Petrou, Michael A TaliasJournal of Pharmaceutical Policy and Practice|May 23, 2019
Hypertension control among euvolemic hypertensive hemodialysis patients in Malaysia: a prospective follow-up studyAmjad Khan, Amer Hayat Khan, Azreen Syazril Adnan, et al.Journal of Pharmaceutical Policy and Practice|May 26, 2018
Provider preferences for postoperative analgesia in obese and non-obese patients undergoing ambulatory surgeryAnthony H Bui, David L Feldman, Michael L Brodman, et al.Journal of Pharmaceutical Policy and Practice|July 21, 2018
Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilarsHillel P CohenJournal of Pharmaceutical Policy and Practice|October 26, 2021
Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational studyJia Yin Lee, Abby Shoon Yeun Ang, Nurdalila Mohd Ali, et al.Journal of Pharmaceutical Policy and Practice|May 5, 2022
The effect of adding real-world evidence to regulatory submissions on the breadth of population indicated for rare disease medicine treatment by the European Medicines AgencyRavi JandhyalaPageof 102